![Daniel Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Bell
No más puestos en curso
Perfil
Daniel Bell was the founder who had held the title of Chief Operating & Financial Officer at Bell Biosystems, Inc. which was founded in 2009.
He received an undergraduate degree from Drexel University.
Antiguos cargos conocidos de Daniel Bell.
Empresas | Cargo | Fin |
---|---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Fundador | - |
Formación de Daniel Bell.
Drexel University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Bell